Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Asia Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Published by: Global Markets Direct

Published: Jan. 31, 2009 - 99 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug delivery devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry powder inhaler
3.3 Infusion Systems
3.3.1 Infusion pumps
3.3.2 Syringe pumps
3.3.3 Disposable Infusion sets
3.4 Needle-free Injections
4 Drug Delivery Devices in Asia Pacific
4.1 Drug Delivery Devices Cross Country Comparison (2000-2012)
4.2 Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), 2000-2012
4.3 Drug Delivery Devices, Asia Pacific, Company Share (2006-2007)
5 Drug Delivery Devices In Japan
5.1 Drug Delivery Devices, Japan, Overall Revenues ($ mn), 2000-2012
5.2 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2012
5.3 Drug Delivery Devices, Japan, Distribution Share (2006-2007)
5.3.1 Infusion Systems Distribution Share (2006-2007)
5.3.2 Inhalation Systems Distribution Share (2006-2007)
5.3.3 Needle Free Injections Distribution Share (2006-2007)
5.4 Drug Delivery Devices, Japan, Company Share (2006-2007)
5.4.1 Drug Delivery Devices, Japan, Company Share (2006-2007)
5.4.2 Infusion Systems, Japan, Company Share (2006-2007)
5.4.3 Inhalation Systems, Japan, Company Share (2006-2007)
6 Drug Delivery Devices In China
6.1 Drug Delivery Devices, China, Overall Revenues ($ mn), 2000-2012
6.2 Drug Delivery Devices, China, Category Volume (Units), 2000-2012
6.3 Drug Delivery Devices, China, Distribution Share (2006-2007)
6.3.1 Infusion Systems Distribution Share (2006-2007)
6.3.2 Inhalation Systems Distribution Share (2006-2007)
6.4 Drug Delivery Devices, China, Company Share (2006-2007)
6.4.1 Drug Delivery Devices, China, Company Share (2006-2007)
6.4.2 Infusion Systems, China, Company Share (2006-2007)
6.4.3 Inhalation Systems, China, Company Share (2006-2007)
7 Drug Delivery Devices In Australia
7.1 Drug Delivery Devices, Australia, Overall Revenues ($ mn), 2000-2012
7.2 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2012
7.3 Drug Delivery Devices, Australia, Distribution Share (2006-2007)
7.3.1 Infusion Systems Distribution Share (2006-2007)
7.3.2 Inhalation Systems Distribution Share (2006-2007)
7.4 Drug Delivery Devices, Australia, Company Share (2006-2007)
7.4.1 Drug Delivery Devices, Australia, Company Share (2006-2007)
7.4.2 Infusion Systems, Australia, Company Share (2006-2007)
7.4.3 Inhalation Systems, Australia, Company Share (2006-2007)
8 Drug Delivery Devices In India
8.1 Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
8.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2012
8.3 Drug Delivery Devices, India, Distribution Share (2006-2007)
8.3.1 Infusion Systems Distribution Share (2006-2007)
8.3.2 Inhalation Systems Distribution Share (2006-2007)
8.4 Drug Delivery Devices, India, Company Share (2006-2007)
8.4.1 Drug Delivery Devices, India, Company Share (2006-2007)
8.4.2 Infusion Systems, India, Company Share (2006-2007)
8.4.3 Inhalation Systems, India, Company Share (2006-2007)
9 AstraZeneca PLC Company Profile
9.1 Company Overview
10 GlaxoSmithKline plc Company Profile
10.1 Company Overview
11 Cardinal Health, Inc. Company Profile
11.1 Company Overview
11.2 Value Chain Analysis
11.2.1 Manufacturing
11.2.1.1 In House Manufacturing
11.2.1.2 Outsourcing
11.2.2 Product Development
11.2.2.1 Regulatory Approvals
11.2.2.2 Research and Development
11.2.3 Sales and Marketing
11.2.3.1 Partnerships and Alliances
11.2.3.2 Licensing Agreements
12 3M Company Company Profile
12.1 Company Overview
12.2 Value Chain Analysis
12.2.1 Manufacturing
12.2.1.1 In House Manufacturing
12.2.2 Product Development
12.2.2.1 Regulatory Approvals
12.2.2.2 Clinical Trials
12.2.2.3 Research and Development
12.2.3 Sales and Marketing
12.2.3.1 Partnerships and Alliances
12.2.3.2 Licensing Agreements
12.2.3.3 E-distribution
13 Baxter International Inc. Company Profile
13.1 Company Overview
13.2 Value Chain Analysis
13.2.1 Manufacturing
13.2.1.1 In House Manufacturing
13.2.2 Product Development
13.2.2.1 Regulatory Approvals
13.2.2.2 Clinical Trials
13.2.2.3 Research and Development
13.2.3 Sales and Marketing
13.2.3.1 Partnerships and Alliances
13.2.3.2 Licensing Agreements
13.2.3.3 E-distribution
13.3 Baxter International Inc. Pipeline Products
13.3.1 Baxter International Inc. Pipeline Products By Equipment Type
13.3.2 Baxter International Inc. Pipeline Products By Development Stage
13.3.3 Baxter International Inc. Pipeline Products By Therapy Area
13.3.4 Baxter International Inc. Pipeline Products By Clinical Trials
13.3.5 Baxter International Inc. Pipeline Products By News Summary
14 Novartis Medical Nutrition Company Profile
14.1 Company Overview
15 Boehringer Ingelheim GmbH Company Profile
15.1 Company Overview
15.2 Value Chain Analysis
15.2.1 Manufacturing
15.2.1.1 In House Manufacturing
15.2.1.2 Outsourcing
15.2.2 Product Development
15.2.2.1 Regulatory Approvals
15.2.2.2 Clinical Trials
15.2.2.3 Research and Development
15.2.3 Sales and Marketing
15.2.3.1 Licensing Agreements
15.2.3.2 Partnerships and Alliances
16 B. Braun Melsungen AG Company Profile
16.1 Company Overview
16.2 Value Chain Analysis
16.2.1 Manufacturing
16.2.1.1 In House Manufacturing
16.2.1.2 Outsourcing
16.2.2 Product Development
16.2.2.1 Regulatory Approvals
16.2.2.2 Clinical Trials
16.2.2.3 Research and Development
16.2.3 Sales and Marketing
16.2.3.1 Partnerships and Alliances
16.2.3.2 Licensing Agreements
17 AKAS Medical Company Profile
17.1 Company Overview
18 Daiken Medical Co., Ltd. Company Profile
18.1 Company Overview
19 Emco Meditek Private Limited Company Profile
19.1 Company Overview
20 Plenum Technologies Private Limited Company Profile
20.1 Company Overview
21 pSivida Limited Company Profile
21.1 Company Overview
21.2 pSivida Limited Pipeline Products
21.2.1 pSivida Limited Pipeline Products By Equipment Type
21.2.2 pSivida Limited Pipeline Products By Development Stage
21.2.3 pSivida Limited Pipeline Products By Therapy Area
21.2.4 pSivida Limited Pipeline Products By Clinical Trials
21.2.5 pSivida Limited Pipeline Products By News Summary
22 Unomedical Pty Ltd Company Profile
22.1 Company Overview
23 Financial Deals Landscape
23.1 Acquisition
24 Recent Developments
24.1 Product News
24.1.1 Dec 12, 2008: pSivida New Clinical Trial For Drug Delivery Device In AMD
24.1.2 Dec 03, 2008: pSivida’s BrachySil Pancreatic Cancer Treatment Featured On The BBC
24.1.3 Jul 07, 2008: BrachySil Phase IIb Pancreatic Cancer Trials Commence
24.1.4 Jan 28, 2008: BioSphere Medical Receives Market Clearance To Sell Embosphere Microspheres In The People's Republic Of China
25 APPENDIX
25.1 Global Markets Direct Research Methodology
25.2 Coverage
25.3 Secondary Research
25.4 Primary Research
25.5 Models
25.6 Forecasts
25.7 Expert Panels
25.8 Currency Conversion
25.9 Contact Us
25.10 Disclaimer
1.1 List of Tables
Table 1: Drug Delivery Devices, Asia Pacific, Cross Country Comparison, Revenues ($ mn), (2000-2012)
Table 2: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), 2000-2012
Table 3: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), 2000-2012
Table 4: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Historic, 2000-2007
Table 5: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Forecast, 2007-2012
Table 6: Drug Delivery Devices, Asia Pacific, Company Share by Revenue ($ mn), 2006-2007
Table 7: Drug Delivery Devices, Japan, Overall Revenues ($ mn), 2000-2012
Table 8: Drug Delivery Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 9: Drug Delivery Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 10: Drug Delivery Devices, Japan, Category Volume (Units), 2000-2012
Table 11: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2007
Table 12: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2007-2012
Table 13: Infusion Systems, Japan, Distribution Share by Revenue ($mn), 2006-2007
Table 14: Inhalation Systems, Japan, Distribution Share by Revenue ($mn), 2006-2007
Table 15: Needle Free Injections, Japan, Distribution Share by Revenue ($mn), 2006-2007
Table 16: Drug Delivery Devices, Japan, Company Share by Revenue ($ mn), 2006-2007
Table 17: Infusion Systems, Japan, Company Share by Revenue ($ mn), 2006-2007
Table 18: Inhalation Systems, Japan, Company Share by Revenue ($ mn), 2006-2007
Table 19: Drug Delivery Devices, China, Overall Revenues ($ mn), 2000-2012
Table 20: Drug Delivery Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
Table 21: Drug Delivery Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
Table 22: Drug Delivery Devices, China, Category Volume (Units), 2000-2012
Table 23: Drug Delivery Devices, China, Category Volume (Units), Historic, 2000-2007
Table 24: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2007-2012
Table 25: Infusion Systems, China, Distribution Share by Revenue ($mn), 2006-2007
Table 26: Inhalation Systems, China, Distribution Share by Revenue ($mn), 2006-2007
Table 27: Drug Delivery Devices, China, Company Share by Revenue ($ mn), 2006-2007
Table 28: Infusion Systems, China, Company Share by Revenue ($ mn), 2006-2007
Table 29: Inhalation Systems, China, Company Share by Revenue ($ mn), 2006-2007
Table 30: Drug Delivery Devices, Australia, Overall Revenues ($ mn), 2000-2012
Table 31: Drug Delivery Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007
Table 32: Drug Delivery Devices, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
Table 33: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2012
Table 34: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2007
Table 35: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2007-2012
Table 36: Infusion Systems, Australia, Distribution Share by Revenue ($mn), 2006-2007
Table 37: Inhalation Systems, Australia, Distribution Share by Revenue ($mn), 2006-2007
Table 38: Drug Delivery Devices, Australia, Company Share by Revenue ($ mn), 2006-2007
Table 39: Infusion Systems, Australia, Company Share by Revenue ($ mn), 2006-2007
Table 40: Inhalation Systems, Australia, Company Share by Revenue ($ mn), 2006-2007
Table 41: Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
Table 42: Drug Delivery Devices, India, Overall Revenues ($ mn), Historic, 2000-2007
Table 43: Drug Delivery Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012
Table 44: Drug Delivery Devices, India, Category Volume (Units), 2000-2012
Table 45: Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2007
Table 46: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2007-2012
Table 47: Infusion Systems, India, Distribution Share by Revenue ($mn), 2006-2007
Table 48: Inhalation Systems, India, Distribution Share by Revenue ($mn), 2006-2007
Table 49: Drug Delivery Devices, India, Company Share by Revenue ($ mn), 2006-2007
Table 50: Infusion Systems, India, Company Share by Revenue ($ mn), 2006-2007
Table 51: Inhalation Systems, India, Company Share by Revenue ($ mn), 2006-2007
Table 52: Baxter International Inc. Pipeline Products by Equipment Type
Table 53: Baxter International Inc. Pipeline Products By Development Stage
Table 54: Baxter International Inc. Pipeline Products By Therapy Area
Table 55: Baxter International Inc. Pipeline Products By Clinical Trials
Table 56: Baxter International Inc. Pipeline Products By News Summaries
Table 57: pSivida Limited Pipeline Products by Equipment Type
Table 58: pSivida Limited Pipeline Products By Development Stage
Table 59: pSivida Limited Pipeline Products By Therapy Area
Table 60: pSivida Limited Pipeline Products By Clinical Trials
Table 61: pSivida Limited Pipeline Products By News Summaries
Table 62: Smiths Group Acquires Zhejiang Zheda Medical Instrument
Table 63: Clinical Cell Culture Merges With Visiomed Group
Table 64: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
Figure 1: Drug Delivery Devices, Asia Pacific, Cross Country Comparison, Revenues ($ mn), (2000-2012)
Figure 2: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), 2000-2012
Figure 3: Drug Delivery Devices, Asia Pacific, Portfolio Analysis, 2000-2012
Figure 4: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Historic, 2000-2007
Figure 5: Drug Delivery Devices, Asia Pacific, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 6: Drug Delivery Devices, Asia Pacific, Company Share (%), 2007
Figure 7: Drug Delivery Devices, Japan, Overall Revenues ($ mn), 2000-2012
Figure 8: Drug Delivery Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 9: Drug Delivery Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 10: Drug Delivery Devices, Japan, Category Volume (Units), 2000-2012
Figure 11: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2000-2007
Figure 12: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2007-2012
Figure 13: Drug Delivery Devices, Japan, Company Share (%), 2007
Figure 14: Infusion Systems, Japan, Company Share (%), 2007
Figure 15: Inhalation Systems, Japan, Company Share (%), 2007
Figure 16: Drug Delivery Devices, China, Overall Revenues ($ mn), 2000-2012
Figure 17: Drug Delivery Devices, China, Overall Revenues ($ mn), Historic, 2000-2007
Figure 18: Drug Delivery Devices, China, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 19: Drug Delivery Devices, China, Category Volume (Units), 2000-2012
Figure 20: Drug Delivery Devices, China, Category Volume (Units), Historic, 2000-2007
Figure 21: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2007-2012
Figure 22: Drug Delivery Devices, China, Company Share (%), 2007
Figure 23: Infusion Systems, China, Company Share (%), 2007
Figure 24: Inhalation Systems, China, Company Share (%), 2007
Figure 25: Drug Delivery Devices, Australia, Overall Revenues ($ mn), 2000-2012
Figure 26: Drug Delivery Devices, Australia, Overall Revenues ($ mn), Historic, 2000-2007
Figure 27: Drug Delivery Devices, Australia, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 28: Drug Delivery Devices, Australia, Category Volume (Units), 2000-2012
Figure 29: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2000-2007
Figure 30: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2007-2012
Figure 31: Drug Delivery Devices, Australia, Company Share (%), 2007
Figure 32: Infusion Systems, Australia, Company Share (%), 2007
Figure 33: Inhalation Systems, Australia, Company Share (%), 2007
Figure 34: Drug Delivery Devices, India, Overall Revenues ($ mn), 2000-2012
Figure 35: Drug Delivery Devices, India, Overall Revenues ($ mn), Historic, 2000-2007
Figure 36: Drug Delivery Devices, India, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 37: Drug Delivery Devices, India, Category Volume (Units), 2000-2012
Figure 38: Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2007
Figure 39: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2007-2012
Figure 40: Drug Delivery Devices, India, Company Share (%), 2007
Figure 41: Infusion Systems, India, Company Share (%), 2007
Figure 42: Inhalation Systems, India, Company Share (%), 2007
Figure 43: Cardinal Health, Inc. Value Chain Analysis
Figure 44: 3M Healthcare Value Chain Analysis
Figure 45: Baxter International Inc. Value Chain Analysis
Figure 46: Boehringer Ingelheim GmbH Value Chain Analysis
Figure 47: B. Braun Melsungen AG Value Chain Analysis
Figure 48: Global Markets Direct Methodology

Abstract

Asia Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Asia Pacific drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in Asia Pacific

Scope
  • The report provides drug delivery devices information broken down into detailed categories in the Asia Pacific.
  • Total revenues, products sold and end users.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the drug delivery devices market in Asia Pacific.
  • Evaluate and compare the attractiveness of the market in the region.
  • Identify growth segments and opportunities in each industry sector within the region.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
  • Analyze the competitiveness of the market in the region and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the region.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the region.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2012
2/15/2012 - 32